自然排卵方案与程序化方案在排卵性女性冻融胚胎移植前的比较:多中心随机临床试验
这项多中心随机对照试验纳入中国24个生殖中心4376例计划行冻融单囊胚移植的排卵性女性(20-40岁),1:1随机接受自然排卵方案或程序化激素替代方案准备内膜。意向性分析显示,自然排卵组健康活产率41.6%(910/2185)与程序化组40.6%(890/2191)无显著差异(相对比1.03,95%CI 0.96-1.10;P=0.49)。在达到临床妊娠的患者中,自然排卵组子痫前期风险低于程序化组(2.9% vs 4.6%;相对比0.63,95%CI 0.43-0.94;P=0.02),早期妊娠丢失、胎盘植入谱系疾病、剖宫产和产后出血发生率也较低。自然排卵组周期取消率较高(16.2% vs 11.5%,P<0.001)。
要点
- 排卵性女性冻融单囊胚移植前,自然排卵方案健康活产率41.6%(910/2185)与程序化方案40.6%(890/2191)相当(相对比1.03,95%CI 0.96-1.10;P=0.49)。
- 达到临床妊娠者中,自然排卵组子痫前期发生率2.9%(38/1302)低于程序化组4.6%(61/1326)(相对比0.63,95%CI 0.43-0.94;P=0.02)。
- 自然排卵组早期妊娠丢失12.1%(158/1302)低于程序化组15.2%(201/1326)(相对比0.80,95%CI 0.66-0.97)。
- 自然排卵组胎盘植入谱系疾病1.8%(24/1302)低于程序化组3.6%(48/1326)(相对比0.51,95%CI 0.31-0.83)。
- 自然排卵组周期取消率16.2%(354/2185)高于程序化组11.5%(251/2191)(P<0.001)。
适用人群与场景
- 排卵性女性,年龄20-40岁,计划行冻融单囊胚移植。
- 来自中国24个学术生殖中心。
处置流程与药物剂量
- 自然排卵方案组:通过监测自然卵泡发育和测定血清促黄体生成素、雌二醇和孕酮水平确定内膜准备和冻融胚胎移植时机。
- 程序化方案组:通过序贯给予雌激素和孕激素实现内膜准备。
研究设计与关键结果
- 多中心、随机、平行组、评估者盲法临床试验,纳入4376例排卵性女性,随机1:1接受自然排卵方案或程序化激素替代方案。
- 主要终点健康活产率:自然排卵组41.6%(910/2185)vs 程序化组40.6%(890/2191),相对比1.03(95%CI 0.96-1.10;P=0.49)。
- 达到临床妊娠者中子痫前期风险:自然排卵组2.9%(38/1302)vs 程序化组4.6%(61/1326),相对比0.63(95%CI 0.43-0.94;P=0.02)。
- 早期妊娠丢失:自然排卵组12.1%(158/1302)vs 程序化组15.2%(201/1326),相对比0.80(95%CI 0.66-0.97)。
- 胎盘植入谱系疾病:自然排卵组1.8%(24/1302)vs 程序化组3.6%(48/1326),相对比0.51(95%CI 0.31-0.83)。
- 剖宫产:自然排卵组69.5%(776/1117)vs 程序化组75.6%(831/1100),相对比0.92(95%CI 0.87-0.97)。
- 产后出血:自然排卵组2.0%(22/1117)vs 程序化组6.1%(67/1100),相对比0.32(95%CI 0.20-0.52)。
- 周期取消率:自然排卵组16.2%(354/2185)vs 程序化组11.5%(251/2191),P<0.001。出生体重和新生儿并发症两组无差异。
证据类型、等级与局限
- 证据类型:多中心随机对照试验。
- 预设的符合方案分析和亚组分析结果与意向性分析一致。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在排卵性女性冻融胚胎移植前,自然排卵方案在健康活产方面与程序化方案效果相当,但子痫前期、早期妊娠丢失、胎盘植入谱系疾病、剖宫产和产后出血风险更低,作者认为可降低孕期母体并发症风险。
- 自然排卵方案周期取消率较高(16.2% vs 11.5%),选择方案时需权衡周期取消风险与母体并发症获益。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To test the hypothesis that women assigned to a natural ovulation regimen before frozen embryo transfer compared with a programmed regimen would have an increased chance of a healthy live birth and a reduced risk of pre-eclampsia or eclampsia.
DESIGN: Multicentre, randomised, parallel group, assessor blinded clinical trial.
SETTING: 24 academic fertility centres in China.
PARTICIPANTS: 4376 ovulatory women (aged 20-40 years) planning to undergo a frozen single blastocyst transfer.
INTERVENTIONS: Eligible participants were randomised (1:1) to receive a natural ovulation regimen or a programmed regimen of hormone replacement for endometrial preparation. Endometrial preparation and frozen embryo transfer timing were determined in the natural ovulation regimen group by monitoring natural follicle development and measuring serum levels of luteinising hormone, oestradiol, and progesterone. In the programmed regimen group, endometrial preparation was achieved by sequential administration of oestrogen and progesterone.
MAIN OUTCOMES AND MEASURES: Primary outcomes were a healthy live birth and pre-eclampsia or eclampsia after a frozen embryo transfer. Secondary outcomes were cycle cancellation, biochemical pregnancy, clinical pregnancy, ongoing pregnancy, pregnancy loss, ectopic pregnancy, live birth, birth weight, and maternal, fetal, and neonatal complications.
RESULTS: In the intention-to-treat analyses, 910 (41.6%) of 2185 patients in the natural ovulation regimen group and 890 (40.6%) of 2191 in the programmed regimen group achieved a healthy live birth (relative ratio 1.03 (95% confidence interval (CI) 0.96 to 1.10); P=0.49). The risk of pre-eclampsia was lower in the natural ovulation regimen group among patients who achieved clinical pregnancy than in the programmed regimen group (2.9% (38 of 1302) v 4.6% (61 of 1326); 0.63 (0.43 to 0.94); P=0.02). The incidences of early pregnancy loss (12.1% (158 of 1302) v 15.2% (201 of 1326); 0.80 (0.66 to 0.97)), placental accreta spectrum (1.8% (24 of 1302) v 3.6% (48 of 1326); 0.51 (0.31 to 0.83)), caesarean section (69.5% (776 of 1117) v 75.6% (831 of 1100); 0.92 (0.87 to 0.97)), and postpartum haemorrhage (2.0% (22 of 1117) v 6.1% (67 of 1100); 0.32 (0.20 to 0.52)) were lower in the natural ovulation regimen group. No differences between groups were observed for birth weight or neonatal complications. The rate of cycle cancellation was higher in the natural ovulation regimen (16.2% (354 of 2185) v 11.5% (251 of 2191), P<0.001). The prespecified per protocol and subgroup analyses yielded results consistent with the intention-to-treat analyses.
CONCLUSIONS: In ovulatory women, a natural ovulation regimen for endometrial preparation was as effective as programmed regimen in terms of achieving a healthy live birth after frozen embryo transfer, but with a lower risk of maternal complications during pregnancy.
TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2200057990.
参考来源
- Wei D, Qin Y, Sun Y, et al. Natural ovulation versus programmed regimens before frozen embryo transfer in ovulatory women: multicentre, randomised clinical trial. BMJ. 2026. PMID: 41565309. doi:10.1136/bmj-2025-087045
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。